CytomX Therapeutics
Price & Volume
Stats
See more52W Range | $0.40-$3.09 |
Market Cap | $292.7M |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $141.1M |
Revenue Growth (YoY) | -25.7% |
Gross Profit (12 Mos) | $141.1M |
Diluted EPS | $0.50 |
News
See moreYahoo Finance • 8 days ago
CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 16 days ago
CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025
Yahoo Finance • last month
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Yahoo Finance • 3 months ago
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
About
CEO | Dr. Sean A. McCarthy DPHIL |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 119 |
